Osteopathies and chondropathies

M13_OSTEOCHONDRO

secondary hypertrophic osteoarthropathy: Symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart. (Dorland, 27th ed)

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 M80-M94, M90.6*C40.99, M90.6*C41.99
Cause of death: ICD-10 M80-M94, M90.6*C40.99, M90.6*C41.99

2 out of 7 registries used, show all original rules.

17695

diagram downward connector

Check minimum number of events None

17695

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

19263

diagram downward connector
M13_OSTEOCHONDRO

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 19263 12153 7110
Unadjusted prevalence (%) 5.11 5.77 4.28
Mean age at first event (years) 53.40 54.98 50.68

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.99 [2.39, 3.76] 2.7e-21 2407
15 years 0.01 1.42 [1.19, 1.70] 1.2e-4 753
5 years 0.00 4.35 [3.82, 4.96] <1e-100 867
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: M13_OSTEOCHONDRO – Osteopathies and chondropathies
GWS hits:

Survival analyses between endpoints

Plot

before Osteopathies and chondropathies
after Osteopathies and chondropathies

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Osteopathies and chondropathies

Endpoint not on priority list, no data to show.